Eyougene Biotech secures RMB100 million+ Series B financing
In Jan., Shanghai Eyougene Biotechnology Development Co., Ltd. (Eyougene Biotech) completed a Series B funding round securing over USD14 million (RMB100 million) from the leading investor Huadian Fund, followed by Lingdu Capital. The financing procee...
Bio-based Material Quarterly Newsletter Q1 2023